Elvitegravir free base
Elvitegravir is an HIV integrase inhibitor.
For research use only. Not for human or veterinary use.
Elvitegravir structure
CAS No.: 697761-98-1
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 500 mg | USD 450.00 | BP-02494-500mg | In stock | Get quote |
| 1 g | USD 685.00 | BP-02494-1g | In stock | Get quote |
| 5 g | USD 1,250.00 | BP-02494-5g | In stock | Get quote |
| 10 g | USD 1,849.00 | BP-02494-10g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
Elvitegravir (GS-9137; JTK-303; D06677) is an HIV integrase inhibitor for HIV-1IIIB, HIV-2EHO and HIV-2ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.
Biological activity
Elvitegravir also inhibits PBMC and PA with IC50 of 0.89 and 20 nM, respectively. Elvitegravir (also known as JTK-303/GS-9137) blocked the integration of HIV-1 cDNA through the inhibition of DNA strand transfer. EVG inhibited the replication of HIV-1, including various subtypes and multiple-drug-resistant clinical isolates, and HIV-2 strains with a 50% effective concentration in the subnanomolar to nanomolar range. The replication capacity of EVG-resistant variants was significantly reduced relative to both wild-type virus and other IN inhibitor-resistant variants selected by L-870810. Elvitegravir (GS-9137) is active against HIV-1 and HIV-2 and has a serum-free antiviral IC50 of 0.3-0.9 nM in peripheral blood mononuclear cells. According to the results of the phase II clinical trial, patients taking once-daily elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease inhibitor. Elvitegravir is currengly in a Phase III clinical trial in the treatment of HIV-1 Infection.
Identifiers
- SMILES
-
COC1=C(CC2=CC=CC(Cl)=C2F)C=C2C(=O)C(=CN([C@H](CO)C(C)C)C2=C1)C(O)=O - InChIKey
-
JUZYLCPPVHEVSV-LJQANCHMSA-N
Specifications
- MW (average)
- 447.8840
- Formula
- C23H23ClFNO5
- CAS No.
- 697761-98-1
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 6 months
Solubility
Soluble in DMSO
Documents
References
Same research area
Search Infection- BP-00892 Ziresovir free base · >98%
- BP-01828 3-Deazaneplanocin A free base · >98%
- BP-01851A Icotinib hydrochloride salt · >98%
- BP-01860 ABX464 free base · >98%
- BP-01870 Oteseconazole free base · >98%
- BP-01871 Quilseconazole free base · >98%
- BP-01872 GSK2330672 free base · >98%
- BP-01908 AZD3759 free base · >99%